Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for Recurrent Pancreatitis
NCT02743364Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Sep 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of simvastatin in acute pancreatitis (AP), sponsored by National Cancer Institute. Started Sep 2016; status: completed.
02
Drugs
simvastatin
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on NCT02743364.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743364.